Patents by Inventor Amy Yasko

Amy Yasko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9512162
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Grant
    Filed: May 26, 2015
    Date of Patent: December 6, 2016
    Assignee: ASED, LLC
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Patent number: 9493773
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: November 15, 2016
    Assignee: ASED, LLC
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Patent number: 9365607
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: June 14, 2016
    Assignee: ASED, LLC
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Publication number: 20150252071
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Application
    Filed: May 26, 2015
    Publication date: September 10, 2015
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Patent number: 9045521
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: June 2, 2015
    Assignee: ASED, LLC
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Publication number: 20150119565
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Application
    Filed: October 10, 2014
    Publication date: April 30, 2015
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Publication number: 20140336181
    Abstract: The present invention relates to nucleic-acid based diagnostics and the use of such diagnostics for the diagnosis of developmental disorders. Novel methods of assessing individuals for the risk of developing autism through the identification of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene alone or in combination with other genes associated with methylation pathways are identified. Methods of identifying those individuals that are at increased and/or decreased risk for developing autism are provided.
    Type: Application
    Filed: November 27, 2013
    Publication date: November 13, 2014
    Inventor: Amy Yasko
  • Patent number: 8859754
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: October 14, 2014
    Assignee: Ased, LLC
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Publication number: 20140039178
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Application
    Filed: July 31, 2012
    Publication date: February 6, 2014
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Publication number: 20140039175
    Abstract: The present invention is directed towards the synthesis of high purity deuterated sugars, deuterated phosphoramidites, deuterated nucleobases, deuterated nucleosides, deuterated oligonucleotides, and deuterated RNA's of defined sequences which can exhibit biochemically useful and biologically valuable properties, thus having potential for therapeutic uses.
    Type: Application
    Filed: July 31, 2012
    Publication date: February 6, 2014
    Inventors: Suresh C. Srivastava, Amy Yasko
  • Publication number: 20130317006
    Abstract: The present invention relates to nucleic-acid based diagnostics and the use of such diagnostics for the diagnosis of developmental disorders. Novel methods of assessing individuals for the risk of developing autism through the identification of mutations of the CFTR gene alone or in combination with other genes associated with the methylation pathways are identified. Methods of identifying those individuals that are at increased and/or decreased risk for developing autism are provided.
    Type: Application
    Filed: May 24, 2012
    Publication date: November 28, 2013
    Inventor: Amy Yasko